Companies that develop, manufacture, or supply vaccines through U.S. operations include Merck, Pfizer, Moderna, Sanofi, GSK, CSL Seqirus, Novavax, and Dynavax. A vaccine sold in the United States is not necessarily manufactured entirely within the country.
Answer
U.S.-headquartered vaccine companies include Merck & Co., Pfizer, Moderna, Novavax, and Dynavax. Foreign-headquartered manufacturers such as Sanofi, GSK, and CSL Seqirus also maintain substantial U.S. manufacturing, formulation, filling, research, or distribution operations. Important vaccine-production locations include facilities in Pennsylvania, North Carolina, Massachusetts, and other biotechnology and pharmaceutical manufacturing centers.
The phrase “made in the USA” requires careful interpretation. Vaccine manufacturing involves multiple stages: antigen or drug-substance production, formulation, sterile filling, packaging, testing, and regulatory batch release. These stages may occur in different countries or at facilities operated by contract manufacturers. U.S. headquarters or FDA approval alone does not prove that every manufacturing step occurs domestically.
Examples of companies supplying the U.S. market include:
• Merck: HPV, MMR, varicella, pneumococcal, and other vaccines
• Pfizer: pneumococcal, RSV, meningococcal, and COVID-19 vaccines
• Moderna: mRNA-based respiratory vaccines
• Sanofi, GSK, and CSL Seqirus: pediatric, adult, and influenza vaccines
• Dynavax: adult hepatitis B vaccination
• Novavax: protein-based vaccine technology supplied through manufacturing partnerships
Buyers should confirm manufacturing sites in the current FDA package insert or biologics license information. The FDA’s licensed vaccine records provide the appropriate regulatory reference.

Trust Our Expert Answers?
Build a Broader Healthcare Portfolio
AdvaCare Pharma supports international distributors with pharmaceuticals, medical devices, veterinary products, and regulatory-focused manufacturing solutions.

